单例肺结核患者9年病程中广泛耐药演化的动态分析
该研究对一例肺结核患者9年间连续分离的结核分枝杆菌进行全基因组测序。感染株初始为异烟肼耐药,治疗期间逐步累积对另外8种抗生素的耐药突变,异质性耐药常见,不同耐药克隆随治疗方案变化交替主导菌群,主要选择压力为抗生素治疗。
要点
- 耐药突变随治疗方案的调整而逐步累积,异质性耐药与同一药物多种突变亚群共存常见。
- 不同时间点由不同耐药克隆主导菌群,其消长与治疗方案变化相吻合。
- 未检出搭便车、代偿性或毒力增强突变,提示抗生素治疗是主导选择压力。
核心结论
- 结核分枝杆菌在单例患者长期治疗过程中呈动态、逐步的广泛耐药演化,异质性耐药常见,抗生素治疗是主要选择压力,凸显快速药敏试验的重要性。
研究设计与样本
- 对一例肺结核患者9年间连续分离的结核分枝杆菌分离株进行全基因组测序。
主要发现
- 感染株为异烟肼耐药,治疗期间逐步累积对另外8种抗生素的耐药突变。
- 异质性耐药常见,对同一药物最多有3种不同耐药突变的亚群共存。
- 不同耐药克隆在不同时间点交替主导菌群,且与治疗方案变化时的耐药突变相吻合。
- 耐药突变占主导,未检出搭便车、代偿性或毒力增强突变。
临床怎么用
- 提示应重视结核分枝杆菌感染菌群的动态性与异质性,依靠快速抗生素敏感性试验指导治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mycobacterium tuberculosis is one of the hardest to treat bacterial pathogens with a high capacity to develop antibiotic resistance by mutations. Here we have performed whole-genome sequencing of consecutive M. tuberculosis isolates obtained during 9 years from a patient with pulmonary tuberculosis. The infecting strain was isoniazid resistant and during treatment it stepwise accumulated resistance mutations to 8 additional antibiotics. Heteroresistance was common and subpopulations with up to 3 different resistance mutations to the same drug coexisted. Sweeps of different resistant clones dominated the population at different time points, always coupled to resistance mutations coinciding with changes in the treatment regimens. Resistance mutations were predominant and no hitch-hiking, compensatory, or virulence-increasing mutations were detected, showing that the dominant selection pressure was antibiotic treatment. The results highlight the dynamic nature of M. tuberculosis infection, population structure, and resistance evolution and the importance of rapid antibiotic susceptibility tests to battle this pathogen.
引用
- Hjort K, Jurén P, Toro JC, et al. Dynamics of Extensive Drug Resistance Evolution of Mycobacterium tuberculosis in a Single Patient During 9 Years of Disease and Treatment. J Infect Dis. 2022. PMID: 33045067. doi:10.1093/infdis/jiaa625
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。